Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone maintenance in Bipolar I Disorder
NCT00280566Phase 3Completed
- Sponsor
- Viatris
- Start
- Dec 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Started Dec 2005; status: completed.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00280566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280566.